Quantcast

Posts related to ‘Revilimid’

Celgene Proves Riskier Than Imagined (CELG)

Celgene Corp. (NASDAQ:CELG) is seeing the price of its shares crushed today after trial results were shown on Sunday at the 49th annual American Society of Hematology (ASH) Meeting of ...
Read Full Story »